Tepotinib (Standard)

Overview

Tepotinib (Standard) is the analytical standard of Tepotinib. This product is intended for research and analytical applications. Tepotinib (EMD-1214063) is an orally active and highly selective, reversible, ATP-competitive c-Met inhibitor with an IC 50 of 3 nM, >200-fold selective for c-Met than IRAK4 , TrkA , Axl , IRAK1 , and Mer . Tepotinib inhibits c-Met phosphorylation. Tepotinib has antitumor effects.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Others | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > c-Met/HGFR | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-14721R
• CAS No.: 1100598-32-0
• Molecular Formula: C29H28N6O2
• Molecular Weight: 492.57
• Purity: 98.44%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source